Characterization of an Anti-CD5 Directed CAR T-Cell against T-Cell Malignancies-Reference-Cited by-同舟云学术

Characterization of an Anti-CD5 Directed CAR T-Cell against T-Cell Malignancies

Published:2020-02-01 Issue:2 Volume:16 Page:369-384
ISSN:2629-3269
Container-title:Stem Cell Reviews and Reports
language:en
Short-container-title:Stem Cell Rev and Rep

Author:

Wada Masayuki,Zhang Hongyu,Fang Liu,Feng Jia,Tse Charlotte Olivia,Zhang Wenli,Chen Qi,Sha Sha,Cao Yuanzhen,Chen Kevin H.,Pinz Kevin G.,Chen Xi,Fan Xing-Xing,Jiang Xun,Ma Yupo^ORCID

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1007/s12015-019-09937-9.pdf

Reference36 articles.

1. Firor, A. E., Jares, A., & Ma, Y. (2015). From humble beginnings to success in the clinic: Chimeric antigen receptor-modified T-cells and implications for immunotherapy. Experimental Biology and Medicine, 240(8), 1087–1098.

2. Brentjens, R. J., Davila, M. L., Riviere, I., Park, J., Wang, X., Cowell, L. G., et al. (2013). CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia. Sci Transl Med, 5(177), 177ra138.

3. Arai, S., Meagher, R., Swearingen, M., Myint, H., Rich, E., Martinson, J., & Klingemann, H. (2008). Infusion of the allogeneic cell line NK-92 in patients with advanced renal cell cancer or melanoma: A phase I trial. Cytotherapy, 10(6), 625–632.

4. Maus, M. V., Grupp, S. A., Porter, D. L., & June, C. H. (2014). Antibody-modified T cells: CARs take the front seat for hematologic malignancies. Blood, 123(17), 2625–2635.

5. Maude, S. L., Frey, N., Shaw, P. A., Aplenc, R., Barrett, D. M., Bunin, N. J., Chew, A., Gonzalez, V. E., Zheng, Z., Lacey, S. F., Mahnke, Y. D., Melenhorst, J. J., Rheingold, S. R., Shen, A., Teachey, D. T., Levine, B. L., June, C. H., Porter, D. L., & Grupp, S. A. (2014). Chimeric antigen receptor T cells for sustained remissions in leukemia. The New England Journal of Medicine, 371(16), 1507–1517.

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. T cell-redirecting therapies in hematological malignancies: Current developments and novel strategies for improved targeting;Molecular Therapy;2024-09

2. Advances in CAR-T-cell therapy in T-cell malignancies;Journal of Hematology & Oncology;2024-06-24

3. Therapeutic potential of CRISPR/CAS9 genome modification in T cell-based immunotherapy of cancer;Cytotherapy;2024-05

4. CD5 blockade, a novel immune checkpoint inhibitor, enhances T cell anti-tumour immunity and delays tumour growth in mice harbouring poorly immunogenic 4T1 breast tumour homografts;Frontiers in Immunology;2024-02-29

5. Progress and Pitfalls of Chimeric Antigen Receptor T Cell Immunotherapy against T Cell Malignancies;Transplantation and Cellular Therapy;2024-02